Nordic Capital acquires majority share in medtech corpuls
Summary
Nordic Capital is to acquire a majority share in corpuls, a medical technology company specialising in emergency medical solutions and cardiac resuscitation, with a key focus on the external defibrillator segment. The founding family of corpuls will remain invested in the company and represented on the management board. corpuls develops a range of medical products and solutions, including advanced life support defibrillators and monitoring devices, automated external defibrillators, chest compression devices as well as telemedicine and software solutions. Nordic Capital has more than 30 years of experience in supporting the growth of healthcare and technology companies globally, and is an active investor in the DACH region. The transaction is subject to customary closing conditions, including relevant regulatory approvals with completion being expected at the end of Q2 or the beginning of Q3 2023.